Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.

Standard

Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy. / Haese, Alexander; Huland, E; Graefen, M; Hammerer, P; Noldus, J; Huland, H.

in: J UROLOGY, Jahrgang 161, Nr. 4, 4, 1999, S. 1206-1211.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Haese A, Huland E, Graefen M, Hammerer P, Noldus J, Huland H. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy. J UROLOGY. 1999;161(4):1206-1211. 4.

Bibtex

@article{2dfdf9b8be6a43948e83cbaf6f18fa2a,
title = "Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.",
abstract = "PURPOSE: We validated our ultrasensitive prostate specific antigen (PSA) assay based on lyophilization and 4-fold concentration of patient sera with the clinical long-term followup and according to histopathological characteristics of 422 patients treated with radical retropubic prostatectomy for prostate cancer. MATERIALS AND METHODS: Each serum sample was divided into 2 aliquots for standard and 4-fold concentrated (ultrasensitive) detection. Samples were analyzed by the same unmodified DPC-Immulite PSA assay. Biochemical relapse was defined as an increase of at least 0.10 ng./ml. in native serum (equivalent to 0.025 ng./ml. in concentrated serum). Mean followup was 449 days (range 29 to 2,057). Kaplan-Meier analysis of standard and ultrasensitive detection results was done, and findings were correlated with pathological stage, Gleason grade, total cancer volume, Gleason grade 4 cancer volume and margin status. Significance of earlier detection in ultrasensitive versus standard detection was calculated with the log rank (Mantel-Cox) test with p",
author = "Alexander Haese and E Huland and M Graefen and P Hammerer and J Noldus and H Huland",
year = "1999",
language = "Deutsch",
volume = "161",
pages = "1206--1211",
journal = "J UROLOGY",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.

AU - Haese, Alexander

AU - Huland, E

AU - Graefen, M

AU - Hammerer, P

AU - Noldus, J

AU - Huland, H

PY - 1999

Y1 - 1999

N2 - PURPOSE: We validated our ultrasensitive prostate specific antigen (PSA) assay based on lyophilization and 4-fold concentration of patient sera with the clinical long-term followup and according to histopathological characteristics of 422 patients treated with radical retropubic prostatectomy for prostate cancer. MATERIALS AND METHODS: Each serum sample was divided into 2 aliquots for standard and 4-fold concentrated (ultrasensitive) detection. Samples were analyzed by the same unmodified DPC-Immulite PSA assay. Biochemical relapse was defined as an increase of at least 0.10 ng./ml. in native serum (equivalent to 0.025 ng./ml. in concentrated serum). Mean followup was 449 days (range 29 to 2,057). Kaplan-Meier analysis of standard and ultrasensitive detection results was done, and findings were correlated with pathological stage, Gleason grade, total cancer volume, Gleason grade 4 cancer volume and margin status. Significance of earlier detection in ultrasensitive versus standard detection was calculated with the log rank (Mantel-Cox) test with p

AB - PURPOSE: We validated our ultrasensitive prostate specific antigen (PSA) assay based on lyophilization and 4-fold concentration of patient sera with the clinical long-term followup and according to histopathological characteristics of 422 patients treated with radical retropubic prostatectomy for prostate cancer. MATERIALS AND METHODS: Each serum sample was divided into 2 aliquots for standard and 4-fold concentrated (ultrasensitive) detection. Samples were analyzed by the same unmodified DPC-Immulite PSA assay. Biochemical relapse was defined as an increase of at least 0.10 ng./ml. in native serum (equivalent to 0.025 ng./ml. in concentrated serum). Mean followup was 449 days (range 29 to 2,057). Kaplan-Meier analysis of standard and ultrasensitive detection results was done, and findings were correlated with pathological stage, Gleason grade, total cancer volume, Gleason grade 4 cancer volume and margin status. Significance of earlier detection in ultrasensitive versus standard detection was calculated with the log rank (Mantel-Cox) test with p

M3 - SCORING: Zeitschriftenaufsatz

VL - 161

SP - 1206

EP - 1211

JO - J UROLOGY

JF - J UROLOGY

SN - 0022-5347

IS - 4

M1 - 4

ER -